BBSOAS Research Fruit Fly Drug Repurposing

We know we reached out a lot in December with our fundraising efforts, but it paid off—and we couldn’t have done it without you! Thanks to your support, we raised enough to move forward with our Fruit Fly Drug Repurposing project.

This project has the potential to make a real difference for our families living with BBSOAS, and we want to keep you updated on progress.  Last week, NR2F1 Foundation President, Jennifer Coughlin had the privilege of speaking with Dr. Clement Chow, Professor of Human Genetics at the University of Utah. He shared some fascinating insights on our fruit fly drug repurposing research. Watch the full interview in the video below. It’s just under 12 minutes and well-worth your time to watch and learn.

Carlie Monnier
Vice President of Board of Directors at  | Website

Carlie is the Vice President of the Board of Directors for the NR2F1 Foundation, a registered 501(c)(3) non-profit organization dedicated to those living with rare mutations on the Nr2f1 gene.

With a B.S. in Special Education and a M.S. in Counseling, Carlie has worked at EPU Children’s Center as a Resource Specialist serving parents of children living with disabilities and then directed a parent leadership group for disability advocacy through storytelling and public speaking.

Carlie lives with her husband Jeff and their two daughters, one of whom has the rare Nr2f1 gene mutation, in Royal Oak, Michigan. She wants all Nr2f1 families whose lives have changed dramatically to know they are not alone.

Related Blogs

2025 Biorepository on the Road Graphics with the following dates and locations of collections: · Nashville, TN April 24-25th Westminster, CO June 14-15 St Louis, MO June 18-21 Phoenix, AZ June 27-28 Boston, MA July 10-11 Denver, CO July 18-19 Westminster, CO July 19-20 Windsor Locks, CT July 19-20 Philadelphia, PA Sept 24-27 Atlanta, GA Dec 4-5
Elsa is sitting to the right of her digital poster abstract, smiling and wearing a button up shirt with a lanyard badge
Drawing detailing the phases of bioinformatics from data sources to managing big data to problem solving to drug discovery or drug repurposing